Dihydrocodeine might bring about the release of histamine; as a result this product or service should not be administered during an asthmatic attack and may be administered with warning in sufferers with allergic Diseases. The knowledge under lists described adverse reactions, applying the following frequency classification: FDA provides further details https://danteynbna.yomoblog.com/39084630/a-review-of-dihydrocodeine-tablets-30-mg